Search research articles
Contact Us
Filters
Showing results (21-30 of 82) with videos related to
Page
of 9
Sort By:
Molecular Immunology
|
March 23, 2010
TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity
Nadine Pouw, Elike Treffers-Westerlaken, Anna Mondino, et al.
Pediatric Reports
|
November 15, 2014
Successful use of antihistamines in severe hypereosinophilia
Stefano Vallero, Anna Mondino, Loredana Farinasso, et al.
Human Gene Therapy
|
March 6, 2010
Redirecting the immune response: role of adoptive T cell therapy
Anna Mondino, Valérie Dardalhon, Rodrigo Hess Michelini, et al.
The Journal of Infectious Diseases
|
March 6, 2018
Interleukin-7 Unveils Pathogen-Specific T Cells by Enhancing Antigen-Recall Responses
Nadia Terrazzini, Paola Mantegani, Florian Kern, et al.
European Journal of Immunology
|
September 11, 2002
Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy
Daniela Crespi, Stefania Massa, Veronica Basso, et al.
Oncoimmunology
|
November 19, 2013
Tumor-targeting vaccination instructs graft-vs.-tumor immune responses
Teresa Manzo, Rodrigo Hess Michelini, Tabea Sturmheit, et al.
Pediatric Reports
|
October 31, 2017
Clinical heterogeneity in a family with <i>DKC1</i> mutation, dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome in first cousins
Cristina Olivieri, Anna Mondino, Matteo Chinello, et al.
Cancer Research
|
July 4, 2003
Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes
Annalisa Camporeale, Andrea Boni, Giandomenica Iezzi, et al.
Journal of Cell Science
|
June 3, 2004
The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion
Federico Furlan, Simone Orlando, Carlo Laudanna, et al.
Frontiers in Immunology
|
April 16, 2021
Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
Ken Maes, Anna Mondino, Juan José Lasarte, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 82) with videos related to
Sort By:
Page
of 9
Molecular Immunology
|
March 23, 2010
TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity
Nadine Pouw, Elike Treffers-Westerlaken, Anna Mondino, et al.
Pediatric Reports
|
November 15, 2014
Successful use of antihistamines in severe hypereosinophilia
Stefano Vallero, Anna Mondino, Loredana Farinasso, et al.
Human Gene Therapy
|
March 6, 2010
Redirecting the immune response: role of adoptive T cell therapy
Anna Mondino, Valérie Dardalhon, Rodrigo Hess Michelini, et al.
The Journal of Infectious Diseases
|
March 6, 2018
Interleukin-7 Unveils Pathogen-Specific T Cells by Enhancing Antigen-Recall Responses
Nadia Terrazzini, Paola Mantegani, Florian Kern, et al.
European Journal of Immunology
|
September 11, 2002
Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy
Daniela Crespi, Stefania Massa, Veronica Basso, et al.
Oncoimmunology
|
November 19, 2013
Tumor-targeting vaccination instructs graft-vs.-tumor immune responses
Teresa Manzo, Rodrigo Hess Michelini, Tabea Sturmheit, et al.
Pediatric Reports
|
October 31, 2017
Clinical heterogeneity in a family with <i>DKC1</i> mutation, dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome in first cousins
Cristina Olivieri, Anna Mondino, Matteo Chinello, et al.
Cancer Research
|
July 4, 2003
Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes
Annalisa Camporeale, Andrea Boni, Giandomenica Iezzi, et al.
Journal of Cell Science
|
June 3, 2004
The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion
Federico Furlan, Simone Orlando, Carlo Laudanna, et al.
Frontiers in Immunology
|
April 16, 2021
Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential
Ken Maes, Anna Mondino, Juan José Lasarte, et al.
Page
of 9